Načítá se...

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

PURPOSE: To evaluate the safety and feasibility of the addition of pamidronate to chemotherapy for treatment of osteosarcoma. PATIENTS AND METHODS: We treated 40 patients with osteosarcoma with cisplatin, doxorubicin, and methotrexate with the addition of pamidronate 2 mg/kg/dose (max dose 90 mg) mo...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Meyers, P. A., Healey, J. H., Chou, A. J., Wexler, L. H., Merola, P. R., Morris, C. D., Laquaglia, M. P., Kellick, M. G., Abramson, S. J., Gorlick, R.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	2010
Témata:	Article
On-line přístup:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3059356/ https://ncbi.nlm.nih.gov/pubmed/21472721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25744
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo otaguje tento záznam!

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

Podobné jednotky